Three Medical Laboratories of Genetron Health Have Passed the 2019 Verification of ctDNA Gene Mutation Detection

Release time:2019-08-01

Recently, the External Quality Assessment (also known as Proficiency Testing) of the circulating tumor DNA (ctDNA) gene mutation carried out by the National Center for Clinical Laboratories (NCCL) in 2019, the Beijing Genetron Medical Laboratory Co., Ltd, Shanghai Genetron Medical Laboratory Co., Ltd and Hangzhou Genetron Medical Laboratory Co., Ltd, 3 subsidiaries of Genetron Health, participated in this project and all passed the tests with full score. By far, Genetron Health has passed the NCCL PT for more than 90 times for four consecutive years. Genetron Health will continue to adhere to the quality management philosophy of Quality Comes First and maintain leading QC to ensure the quality of each sample test.


This Proficiency Testing was jointly carried out by the NCCL and the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP). There are 146 Chinese laboratories participating in this test and are evaluated according to four major parts : validity of results, nucleic acid extraction results, qualitative results of gene mutations, and quantitative results of gene mutations. 126 labs have delivered valid results, and 125 labs have qualified nucleic acid extraction results. Only a total of 53 labs passed the test with full score, accounting for only 42.4%.


Three Medical Laboratories of Genetron Health Have Passed the 2019 Verification of ctDNA Gene Mutation Detection


NCCL EQA Certificate of Beijing Genetron Health


Three Medical Laboratories of Genetron Health Have Passed the 2019 Verification of ctDNA Gene Mutation Detection


 NCCL EQA Certificate of Shanghai Genetron Health

Three Medical Laboratories of Genetron Health Have Passed the 2019 Verification of ctDNA Gene Mutation Detection


 NCCL EQA Certificate of Hangzhou Genetron Health


Based on high-throughput sequencing technology, the three medical laboratories of Genetron Health accurately detected various types of mutation sites of tumor samples by their standardized laboratory operations and bioinformatics analysis techniques. Passing the NCCL PT with full score means that the top testing ability and high standard quality system of Genetron Health are once again recognized by the national authorities.


COPYRIGHT © 2020-2023泛生子. ALL RIGHTS RESERVED
Genetron Health Genetron Health Management
COPYRIGHT © 2020-2023泛生子. ALL RIGHTS RESERVED
犀牛云提供云计算服务
Messages
  • *To
  • *Subject
  • *Name
  • *Tel
  • Work Unit
  • *Email
  • 详细说明:
  • Verification code:
Genetron Health Genetron Health Management